4960.T down 4.58% pre market 03 Jan 2026: Top loser on JPX, watch 50-day support
The focus keyword 4960.T shows heavy pre-market weakness on 03 Jan 2026 after the stock opened lower; price is JPY 354.00, down 4.58% from the previous close of JPY 371.00. Chemipro Kasei Kaisha, Ltd. (4960.T) is trading on the JPX in Japan with volume at 62,400.00 shares as traders reassess valuation after a recent run. This article explains the pre-market move, fundamentals, technical signals, and short-term outlook for top losers on the session.
Pre-market price action and immediate drivers
Chemipro Kasei Kaisha, Ltd. (4960.T) is trading at JPY 354.00 pre market on 03 Jan 2026, a decline of JPY -17.00 or -4.58% versus the previous close of JPY 371.00. The stock opened at JPY 365.00 and the intraday range so far is JPY 354.00 to JPY 371.00. Volume sits at 62,400.00 versus an average volume of 223,131.00, indicating below-average early trading interest.
This drop places 4960.T among the session’s top losers on the JPX, driven by profit-taking after a 1‑month gain of 14.38% and a 3‑month gain of 18.44%. Market participants are watching the 50‑day moving average at JPY 332.14 as the next technical support.
Fundamental snapshot: valuation and income metrics
Chemipro reports EPS of JPY 5.81 and a trailing P/E of 60.93, reflecting a premium multiple to peers in the Basic Materials sector where average P/E is ~16.36. Price to book is 1.19 and price to sales is 0.63, showing mixed valuation signals. Market cap is JPY 5,704,018,992.00 and shares outstanding are 16,113,048.00.
Key balance-sheet ratios include debt to equity of 0.95 and a current ratio of 1.30, which show moderate leverage and adequate short-term liquidity. Dividend per share is JPY 3.50 implying a dividend yield of 0.99%.
Technicals and Meyka grade
Short-term technical momentum is mixed: RSI is 60.12 and MACD histogram is positive at 6.41, while ADX at 34.79 signals a strong trend. Bollinger middle band sits at JPY 321.75 and ATR is JPY 17.42, so intraday swings can be significant. Watch support at the 50‑day average JPY 332.14 and resistance near the session high JPY 371.00.
Meyka AI rates 4960.T with a score out of 100: 72.51, Grade B+ with suggestion BUY. This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. These grades are not guaranteed and we are not financial advisors.
Valuation, forecasts and price targets
Meyka AI’s forecast model projects a 12‑month price of JPY 397.25, versus the current price of JPY 354.00, implying upside of 12.22%. The model also lists a monthly projection of JPY 356.25 and a 3‑year target of JPY 451.49. Forecasts are model-based projections and not guarantees.
For scenario planning, a conservative 12‑month target is JPY 330.00 (downside risk to 50‑day support), base case aligns with the Meyka model at JPY 397.25, and a bullish case takes the stock back toward the prior year high of JPY 470.00 if earnings accelerate.
Risks, catalysts and sector context
Primary risks include margin pressure in chemicals, inventory cycles (days of inventory on hand 167.05), and high P/E sensitivity if earnings slow. Net debt to EBITDA is elevated at 4.53, which raises refinancing and interest sensitivity in a rising-rate environment.
Key catalysts are the next earnings release on 06 Feb 2026, any improvement in electronic materials demand, and sector momentum in Basic Materials where 1‑year performance is +10.94% for the sector. Company updates and export demand data will drive near-term moves.
Trading outlook for top losers
As a top pre-market loser on JPX, 4960.T could attract short-term buyers near the 50‑day average JPY 332.14 or trigger further selling if volume expands above the 223,131.00 average. Intraday traders should set stops below JPY 332.14 and consider partial profit-taking on rallies toward JPY 365.00–371.00.
Longer-term investors should weigh the premium P/E and net-debt metrics against steady revenue per share JPY 558.34 and improving free cash flow trends reported in recent filings. Use position sizing to manage volatility given ATR JPY 17.42.
Final Thoughts
Key takeaways for 4960.T stock on 03 Jan 2026: pre-market weakness pushed Chemipro Kasei Kaisha, Ltd. to JPY 354.00, down -4.58%, making it one of the session’s top losers on the JPX. Fundamentals show EPS JPY 5.81, P/E 60.93 and price/book 1.19, while debt to equity is 0.95. Technicals point to short-term support at the 50‑day average JPY 332.14 and resistance near JPY 371.00. Meyka AI rates 4960.T with a score out of 100: 72.51 (B+, BUY), and Meyka AI’s forecast model projects a 12‑month price of JPY 397.25, implying upside of 12.22% versus the current JPY 354.00. Forecasts are model-based projections and not guarantees. Traders should watch the earnings announcement on 06 Feb 2026, volume expansion above 223,131.00, and inventory/receivables trends for confirmation before adding exposure. Meyka AI provides this AI-powered market analysis platform insight to help investors frame risk-reward; always perform your own due diligence.
FAQs
4960.T is down pre-market by -4.58% to JPY 354.00 due to profit-taking after recent gains and investors eyeing valuation (P/E 60.93). Low early volume 62,400.00 suggests directional conviction may still be limited.
Watch support at the 50‑day moving average JPY 332.14 and the Bollinger middle band JPY 321.75. Immediate resistance is the session high area JPY 371.00 and the prior short-term peak near JPY 365.00.
Meyka AI’s forecast model projects a 12‑month price of JPY 397.25 for 4960.T, implying upside of 12.22% from the current JPY 354.00. Forecasts are projections and not guarantees.
Debt to equity of 0.95 and net debt to EBITDA 4.53 increase sensitivity to slower cash flow. Current ratio 1.30 provides limited short-term cushion, so leverage is a notable risk factor.
Disclaimer:
Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.
